The Activation of IL-1-induced enhancers depends on TAK1 kinase activity and NF-κB p65

Cell Reports

Volumn 10, Issue 5, 2015, Pages 726-739

  Jurida, Liane ^a   Soelch, Johanna ^a   Bartkuhn, Marek ^b   Handschick, Katja ^a   Müller, Helmut ^a   Newel, Doris ^a   Weber, Axel ^a   Dittrich Breiholz, Oliver ^c   Schneider, Heike ^c   Bhuju, Sabin ^d   Saul, Vera V ^b   Schmitz, M Lienhard ^b   Kracht, Michael ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE CBP; I KAPPA B KINASE; I KAPPA B KINASE 2; INTERLEUKIN 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN IMMUNOPRECIPITATION SEQUENCING; CHROMOSOME 4; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

EID: 84923349602     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.01.001     Document Type: Article

References (46)

1. Adli M., Baldwin A.S. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J.Biol. Chem. 2006, 281:26976-26984.
2. Aksentijevich I., Masters S.L., Ferguson P.J., Dancey P., Frenkel J., van Royen-Kerkhoff A., Laxer R., Tedgård U., Cowen E.W., Pham T.H., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N.Engl. J. Med. 2009, 360:2426-2437.
3. Bhatt D.M., Pandya-Jones A., Tong A.J., Barozzi I., Lissner M.M., Natoli G., Black D.L., Smale S.T. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 2012, 150:279-290.
4. Birbach A., Gold P., Binder B.R., Hofer E., de Martin R., Schmid J.A. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J.Biol. Chem. 2002, 277:10842-10851.
5. Calo E., Wysocka J. Modification of enhancer chromatin: what, how, and why?. Mol. Cell 2013, 49:825-837.
6. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
7. Dinarello C.A., Simon A., van der Meer J.W. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 2012, 11:633-652.
8. Flintoft L. Gene regulation: Enhancing the hunt for enhancers. Nat. Rev. Genet. 2013, 14:151.
9. Gaestel M., Kotlyarov A., Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discov. 2009, 8:480-499.
10. Garber M., Yosef N., Goren A., Raychowdhury R., Thielke A., Guttman M., Robinson J., Minie B., Chevrier N., Itzhaki Z., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
11. Ghisletti S., Natoli G. Deciphering cis-regulatory control in inflammatory cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2013, 368:20120370.
12. Häcker H., Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, 2006:re13.
13. Handschick K., Beuerlein K., Jurida L., Bartkuhn M., Müller H., Soelch J., Weber A., Dittrich-Breiholz O., Schneider H., Scharfe M., et al. Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-κB-dependent gene expression. Mol. Cell 2014, 53:193-208.
14. Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 2009, 10:281-288.
15. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
16. Hoffmann E., Thiefes A., Buhrow D., Dittrich-Breiholz O., Schneider H., Resch K., Kracht M. MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J.Biol. Chem. 2005, 280:9706-9718.
17. Jin F., Li Y., Ren B., Natarajan R. PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc. Natl. Acad. Sci. USA 2011, 108:5290-5295.
18. Jin F., Li Y., Dixon J.R., Selvaraj S., Ye Z., Lee A.Y., Yen C.A., Schmitt A.D., Espinoza C.A., Ren B. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 2013, 503:290-294.
19. Kasowski M., Grubert F., Heffelfinger C., Hariharan M., Asabere A., Waszak S.M., Habegger L., Rozowsky J., Shi M., Urban A.E., et al. Variation in transcription factor binding among humans. Science 2010, 328:232-235.
20. Li W., Notani D., Ma Q., Tanasa B., Nunez E., Chen A.Y., Merkurjev D., Zhang J., Ohgi K., Song X., et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013, 498:516-520.
21. Lim C.A., Yao F., Wong J.J., George J., Xu H., Chiu K.P., Sung W.K., Lipovich L., Vega V.B., Chen J., et al. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol. Cell 2007, 27:622-635.
22. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., Rinn J.L., Nelson F.K., Miller P., Gerstein M., et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 2003, 100:12247-12252.
23. Mbalaviele G., Sommers C.D., Bonar S.L., Mathialagan S., Schindler J.F., Guzova J.A., Shaffer A.F., Melton M.A., Christine L.J., Tripp C.S., et al. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models. J.Pharmacol. Exp. Ther. 2009, 329:14-25.
24. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
25. Montavon T., Soshnikova N., Mascrez B., Joye E., Thevenet L., Splinter E., de Laat W., Spitz F., Duboule D. A regulatory archipelago controls Hox genes transcription in digits. Cell 2011, 147:1132-1145.
26. Natoli G., Saccani S., Bosisio D., Marazzi I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 2005, 6:439-445.
27. Nelson D.E., Ihekwaba A.E., Elliott M., Johnson J.R., Gibney C.A., Foreman B.E., Nelson G., See V., Horton C.A., Spiller D.G., et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004, 306:704-708.
28. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999, 398:252-256.
29. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., Curina A., Prosperini E., Ghisletti S., Natoli G. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
30. Pennacchio L.A., Bickmore W., Dean A., Nobrega M.A., Bejerano G. Enhancers: five essential questions. Nat. Rev. Genet. 2013, 14:288-295.
31. Perkins N.D. The diverse and complex roles of NF-κB subunits in cancer. Nat. Rev. Cancer 2012, 12:121-132.
32. Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 2012, 33:522-530.
33. Sakurai H., Miyoshi H., Toriumi W., Sugita T. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J.Biol. Chem. 1999, 274:10641-10648.
34. Schmitz M.L., Weber A., Roxlau T., Gaestel M., Kracht M. Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines. Biochim. Biophys. Acta 2011, 1813:2165-2175.
35. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., Young R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 2006, 103:5899-5904.
36. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:E131-E136.
37. Shen Y., Yue F., McCleary D.F., Ye Z., Edsall L., Kuan S., Wagner U., Dixon J., Lee L., Lobanenkov V.V., Ren B. A map of the cis-regulatory sequences in the mouse genome. Nature 2012, 488:116-120.
38. Simonatto M., Barozzi I., Natoli G. Non-coding transcription at cis-regulatory elements: computational and experimental approaches. Methods 2013, 63:66-75.
39. Spitz F., Furlong E.E. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 2012, 13:613-626.
40. Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) pathway. Sci. Signal. 2010, 3:cm1.
41. Wu J., Powell F., Larsen N.A., Lai Z., Byth K.F., Read J., Gu R.F., Roth M., Toader D., Saeh J.C., Chen H. Mechanism and invitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. ACS Chem. Biol. 2013, 8:643-650.
42. Xing Y., Yang Y., Zhou F., Wang J. Characterization of genome-wide binding of NF-κB in TNFα-stimulated HeLa cells. Gene 2013, 526:142-149.
43. Yang J., Mitra A., Dojer N., Fu S., Rowicka M., Brasier A.R. A probabilistic approach to learn chromatin architecture and accurate inference of the NF-κB/RelA regulatory network using ChIP-Seq. Nucleic Acids Res. 2013, 41:7240-7259.
44. Zhang J., Clark K., Lawrence T., Peggie M.W., Cohen P. An unexpected twist to the activation of IKKβ: TAK1 primes IKKβ for activation by autophosphorylation. Biochem. J. 2014, 461:531-537.
45. Zhao B., Barrera L.A., Ersing I., Willox B., Schmidt S.C., Greenfeld H., Zhou H., Mollo S.B., Shi T.T., Takasaki K., et al. The NF-κB genomic landscape in lymphoblastoid B cells. Cell Rep. 2014, 8:1595-1606.
46. Zhu J., Adli M., Zou J.Y., Verstappen G., Coyne M., Zhang X., Durham T., Miri M., Deshpande V., De Jager P.L., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 2013, 152:642-654.